вер . 22, 2025 10:50 Повернутися до списку
The Набір для виявлення генотипування ВПЛ 28 від Cowingene (рідкий) represents a cutting-edge advancement in molecular diagnostics, specifically designed for the identification of 28 high-risk human papillomavirus (HPV) genotypes. Developed by Taizhou Cowingene Biotech Co., Ltd., this kit combines precision, efficiency, and reliability to meet the evolving needs of clinical laboratories and healthcare professionals. This article provides an in-depth analysis of the product's features, technical specifications, applications, and the company's commitment to innovation in molecular diagnostics.
The Cowingene HPV 28 Genotyping Detection Kit is a PCR-based diagnostic tool that enables the simultaneous detection of 28 high-risk HPV genotypes, including 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 55, 56, 58, 59, 61, 66, 68, 73, 81, 82, and 83. This comprehensive coverage ensures early detection of HPV infections associated with cervical cancer and other related conditions. The kit is validated for use with cervical swab, urine, and self-collected vaginal specimens, offering flexibility in sample collection and processing.
Як а ПЛР на вірус папіломи людини ВПЛ solution, the kit employs advanced molecular techniques to deliver accurate and reproducible results. Its liquid-based format simplifies workflow, reduces the risk of cross-contamination, and enhances the efficiency of laboratory operations. The product's design aligns with global standards for molecular diagnostics, ensuring compliance with regulatory requirements and clinical best practices.

зображення: Read More About hpv detection by pcr
The Cowingene HPV 28 Genotyping Detection Kit stands out in the market due to its exceptional features and advantages, which are critical for modern diagnostic laboratories. Below are some of the key attributes:

зображення: Read More About human papilloma virus hpv pcr
| Параметр | Подробиці |
|---|---|
| Назва продукту | Набір для виявлення генотипування ВПЛ 28 від Cowingene (рідкий) |
| Виробник | Taizhou Cowingene Biotech Co., Ltd. |
| Перевірені зразки | Мазок з шийки матки, сеча, самостійно зібраний вагінальний мазок |
| Цільові генотипи | 8 tubes covering 28 high-risk HPV genotypes (16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 55, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) |
| Методологія | Real-time PCR (qPCR) |
| Тип зразка | Liquid-based (no need for DNA extraction in some protocols) |
| Час виконання | Less than 4 hours (depending on laboratory setup) |
| Умови зберігання | -20°C для тривалого зберігання |
| Термін придатності | 12 months from the date of manufacture |

зображення: Read More About human papilloma virus hpv pcr
The Cowingene HPV 28 Genotyping Detection Kit is designed for a wide range of applications in clinical and research settings. Its versatility makes it an ideal tool for:
Заснована в 2015 році, Taizhou Cowingene Biotech Co., Ltd. is a leading biotechnology company specializing in molecular diagnostics and life science research. Based in Taizhou, China, the company has established itself as a trusted provider of innovative diagnostic solutions for infectious diseases, cancer, and genetic disorders.
Cowingene's commitment to quality and innovation is reflected in its state-of-the-art research facilities, rigorous quality control processes, and adherence to international standards. The company's product portfolio includes a wide range of PCR-based assays, immunoassays, and molecular reagents, catering to the needs of clinical laboratories, research institutions, and healthcare providers worldwide.
As a pioneer in the field of molecular diagnostics, Cowingene has received numerous certifications, including ISO 13485:2016 for medical device quality management systems. The company's dedication to continuous improvement and customer satisfaction has earned it a reputation for excellence in the industry.
The Cowingene HPV 28 Genotyping Detection Kit has been rigorously tested and validated to ensure its performance and reliability. According to the Національний інститут стандартів і технологій (NIST), molecular diagnostic assays must meet stringent criteria for accuracy, precision, and reproducibility to be considered reliable for clinical use. The Cowingene kit aligns with these standards, as it has undergone extensive validation studies to confirm its analytical performance and clinical utility.
Furthermore, the product complies with the requirements of the U.S. Food and Drug Administration (FDA) і European Medicines Agency (EMA), ensuring its suitability for use in regulated environments. These certifications underscore Cowingene's commitment to delivering products that meet the highest standards of quality and safety.
The Набір для виявлення генотипування ВПЛ 28 від Cowingene (рідкий) is a testament to the advancements in molecular diagnostics and the critical role of innovative technologies in improving patient outcomes. With its comprehensive genotype coverage, high sensitivity, and flexibility in sample handling, this kit is an essential tool for cervical cancer screening and HPV research.
As a leader in the biotechnology industry, Taizhou Cowingene Biotech Co., Ltd. continues to drive innovation in molecular diagnostics, ensuring that healthcare professionals have access to reliable and efficient solutions. The company's dedication to quality, compliance, and customer satisfaction makes it a trusted partner in the fight against infectious diseases and cancer.
1. Національний інститут стандартів і технологій (NIST). (n.d.). Molecular Diagnostics Standards. Retrieved from https://www.nist.gov
2. Taizhou Cowingene Biotech Co., Ltd.. (n.d.). Product Specifications. Retrieved from https://www.cowingene.com
Пов'язані ПРОДУКЦІЯ
Rapid HPV 16/18/45 Molecular Detection with NATBox for Targeted Cervical Cancer Screening
НовиниApr.24,2026High-Sensitivity HPV (2+16) Molecular Detection for Early Cervical Cancer Screening
НовиниApr.24,2026Comprehensive HPV 28 Genotyping Solution for Advanced Cervical Cancer Screening
НовиниApr.24,2026Comprehensive HPV 15 Genotyping Solution for Accurate Cervical Cancer Risk Assessment
НовиниApr.24,2026Comprehensive 14-Pathogen STI Detection Solution for Accurate Molecular Diagnosis
НовиниApr.24,2026Accurate and Reliable HSV-1/2 Molecular Detection for Clinical Diagnosis
НовиниApr.24,2026